[Podcast] Understanding the Limitations of Proposed Drug Pricing Reforms

Terry Wilcox of the Patients Rising Podcast interviewed Chief Science Policy Officer at Global Healthy Living Foundation Robert Popovian in a recent episode. He was joined by Pam Kohl, a breast cancer patient and advocate, and Kathi Luis of the Amyloidosis Foundation. Despite many promises by Congress, most proposals claiming reduced drug prices are false.

“We sort through the facts and myths of drug pricing, how “middlemen” in the supply chain lead to higher costs and real solutions to lowering out-of-pocket costs for patients. Clinical pharmacist and health economist Dr. Robert Popovian dives into the complicated world of drug pricing and simply explains how it impacts patients’ health and pockets.” Listen to the podcast here.

(Source: Patients Rising Podcast, 10/22/21)